Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis
- 7 July 2005
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 43 (6) , 951-957
- https://doi.org/10.1016/j.jhep.2005.06.006
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Decreased fibrosis during corticosteroid therapy of autoimmune hepatitisJournal of Hepatology, 2004
- Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: A retrospective analysisHepatology, 2002
- Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitisHepatology, 2002
- Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: A randomized placebo-controlled treatment trialHepatology, 1999
- International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitisJournal of Hepatology, 1999
- Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitisJournal of Gastroenterology and Hepatology, 1998
- Prognosis of histological cirrhosis in type 1 autoimmune hepatitisGastroenterology, 1996
- Classification of chronic hepatitis: Diagnosis, grading and stagingHepatology, 1994
- The nature and prognostic implications of autoimmune hepatitis with an acute presentationJournal of Hepatology, 1994
- CONTROLLED TRIAL OF PREDNISONE AND AZATHIOPRINE IN ACTIVE CHRONIC HEPATITISThe Lancet, 1973